{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:58:11Z","timestamp":1787763491626,"version":"build-2784847793"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046653"],"award-info":[{"award-number":["R01DA046653"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite increased availability of take-home naloxone, many people who use opioids do so in unprotected contexts, with no other person who might administer naloxone present, increasing the likelihood that an overdose will result in death. Thus, there is a social nature to being \u201cprotected\u201d from overdose mortality, which highlights the importance of identifying background factors that promote access to protective social networks among people who use opioids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We used respondent-driven sampling to recruit adults residing in New York City who reported recent (past 3-day) nonmedical opioid use (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009575). Participants completed a baseline assessment that included past 30-day measures of substance use, overdose experiences, and number of \u201cprotected\u201d opioid use events, defined as involving naloxone and the presence of another person who could administer it, as well as measures of network characteristics and social support. We used modified Poisson regression with robust variance to estimate unadjusted and adjusted prevalence ratios (PRs) and 95% confidence intervals (CIs).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>66% of participants had ever been trained to administer naloxone, 18% had used it in the past three months, and 32% had experienced a recent overdose (past 30\u00a0days). During recent opioid use events, 64% reported never having naloxone and a person to administer present. This was more common among those: aged\u2009\u2265\u200950\u00a0years (PR: 1.18 (CI 1.03, 1.34); who identified as non-Hispanic Black (PR: 1.27 (CI 1.05, 1.53); experienced higher levels of stigma consciousness (PR: 1.13 (CI 1.00, 1.28); and with small social networks (&lt;\u20095 persons) (APR: 1.14 (CI 0.98, 1.31). Having a recent overdose experience was associated with severe opioid use disorder (PR: 2.45 (CI 1.49, 4.04), suicidality (PR: 1.72 (CI 1.19, 2.49), depression (PR: 1.54 (CI 1.20, 1.98) and positive urinalysis result for benzodiazepines (PR: 1.56 (CI 1.23, 1.96), but not with network size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Results show considerable gaps in naloxone protection among people who use opioids, with more vulnerable and historically disadvantaged subpopulations less likely to be protected. Larger social networks of people who use opioids may be an important resource to curtail overdose mortality, but more effort is needed to harness the protective aspects of social networks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-022-00604-w","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:38:34Z","timestamp":1646383114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-9925","authenticated-orcid":false,"given":"Alex S.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Scheidell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette M.","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luther","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"604_CR1","unstructured":"CDC, Provisional Drug Overdose Death Counts 2021."},{"key":"604_CR2","unstructured":"Ahmad F, Rossen L, Sutton P. Provisisonal drug overdose death counts 2021, National Center for Health Statistics."},{"key":"604_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.drugalcdep.2017.05.001","volume":"178","author":"R McDonald","year":"2017","unstructured":"McDonald R, Campbell ND, Strang J. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids\u2014conception and maturation. Drug Alcohol Depend. 2017;178:176\u201387.","journal-title":"Drug Alcohol Depend"},{"issue":"7044","key":"604_CR4","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/bmj.312.7044.1435","volume":"312","author":"J Strang","year":"1996","unstructured":"Strang J, et al. Heroin overdose: the case for take-home naloxone. BMJ. 1996;312(7044):1435\u20136.","journal-title":"BMJ"},{"issue":"23","key":"604_CR5","first-page":"631","volume":"64","author":"E Wheeler","year":"2015","unstructured":"Wheeler E, et al. Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(23):631\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"604_CR6","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1016\/j.japh.2016.11.007","volume":"57","author":"C Davis","year":"2017","unstructured":"Davis C, Carr D. State legal innovations to encourage naloxone dispensing. J Am Pharm Assoc. 2017;57(2):S180\u20134.","journal-title":"J Am Pharm Assoc"},{"issue":"9","key":"604_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.ajem.2015.05.022","volume":"33","author":"J Rando","year":"2015","unstructured":"Rando J, et al. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths. Am J Emerg Med. 2015;33(9):1201\u20134.","journal-title":"Am J Emerg Med"},{"key":"604_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.drugpo.2019.09.008","volume":"74","author":"S Bessen","year":"2019","unstructured":"Bessen S, et al. Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA. Int J Drug Policy. 2019;74:144\u201351.","journal-title":"Int J Drug Policy"},{"key":"604_CR9","first-page":"e1","volume":"66","author":"C Yang","year":"2021","unstructured":"Yang C, Favaro J, Meacham MC. NEXT harm reduction: an online, mail-based naloxone distribution and harm-reduction program. Am J Public Health. 2021;66:e1\u20135.","journal-title":"Am J Public Health"},{"issue":"2","key":"604_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jurban\/jtg029","volume":"80","author":"PJ Davidson","year":"2003","unstructured":"Davidson PJ, et al. Fatal heroin-related overdose in San Francisco, 1997\u20132000: a case for targeted intervention. J Urban Health. 2003;80(2):261\u201373.","journal-title":"J Urban Health"},{"issue":"3","key":"604_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.drugpo.2013.10.015","volume":"25","author":"A Siegler","year":"2014","unstructured":"Siegler A, et al. Unintentional opioid overdose deaths in New York City, 2005\u20132010: a place-based approach to reduce risk. Int J Drug Policy. 2014;25(3):569\u201374.","journal-title":"Int J Drug Policy"},{"key":"604_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugpo.2018.07.003","volume":"59","author":"K Tobin","year":"2018","unstructured":"Tobin K, et al. Awareness and access to naloxone necessary but not sufficient: examining gaps in the naloxone cascade. Int J Drug Policy. 2018;59:94\u20137.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"604_CR13","doi-asserted-by":"publisher","first-page":"e22411","DOI":"10.2196\/22411","volume":"4","author":"AS Bennett","year":"2020","unstructured":"Bennett AS, et al. Reasons people who use opioids do not accept or carry no-cost naloxone: qualitative interview study. JMIR Form Res. 2020;4(12):e22411.","journal-title":"JMIR Form Res"},{"issue":"11","key":"604_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1371\/journal.pone.0224686","volume":"14","author":"L Dayton","year":"2019","unstructured":"Dayton L, et al. More than just availability: who has access and who administers take-home naloxone in Baltimore, MD. PLoS ONE. 2019;14(11):224\u2013686.","journal-title":"PLoS ONE"},{"key":"604_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.drugpo.2017.09.015","volume":"51","author":"SC Heavey","year":"2018","unstructured":"Heavey SC, et al. \u2018I have it just in case\u2019\u2014Naloxone access and changes in opioid use behaviours. Int J Drug Policy. 2018;51:27\u201335.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"604_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00436-6","volume":"17","author":"K Papamihali","year":"2020","unstructured":"Papamihali K, et al. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada. Harm Reduct J. 2020;17(1):1\u201311.","journal-title":"Harm Reduct J"},{"key":"604_CR17","first-page":"113","volume":"66","author":"J Bowles","year":"2020","unstructured":"Bowles J, et al. \u201cGenerally, you get 86\u2019ed because you\u2019re a liability\u201d: An application of Integrated Threat Theory to frequently witnessed overdoses and social distancing responses. Soc Sci Med. 2020;66:113\u201390.","journal-title":"Soc Sci Med"},{"key":"604_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.drugpo.2019.03.012","volume":"68","author":"CA Latkin","year":"2019","unstructured":"Latkin CA, et al. Stigma and drug use settings as correlates of self-reported, non-fatal overdose among people who use drugs in Baltimore, Maryland. Int J Drug Policy. 2019;68:86\u201392.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"604_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2288-14-42","volume":"14","author":"B Bonevski","year":"2014","unstructured":"Bonevski B, et al. Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med Res Methodol. 2014;14(1):42.","journal-title":"BMC Med Res Methodol"},{"issue":"14","key":"604_CR20","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.3109\/10826089909039440","volume":"34","author":"TG Pierce","year":"1999","unstructured":"Pierce TG. Gen-X Junkie: ethnographic research with young white heroin users in Washington, DC. Substance Use Misuse. 1999;34(14):2095\u2013114.","journal-title":"Substance Use Misuse"},{"issue":"1","key":"604_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugalcdep.2003.09.005","volume":"73","author":"CA Latkin","year":"2004","unstructured":"Latkin CA, Hua W, Tobin K. Social network correlates of self-reported non-fatal overdose. Drug Alcohol Depend. 2004;73(1):61\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"604_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"DD Heckathorn","year":"1997","unstructured":"Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174\u201399.","journal-title":"Soc Probl"},{"key":"604_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev-soc-060116-053556","volume":"43","author":"DD Heckathorn","year":"2017","unstructured":"Heckathorn DD, Cameron CJ. Network sampling: from snowball and multiplicity to respondent-driven sampling. Ann Rev Sociol. 2017;43:101\u201319.","journal-title":"Ann Rev Sociol"},{"key":"604_CR24","first-page":"66","volume":"6","author":"ER Pouget","year":"2017","unstructured":"Pouget ER, et al. Recent overdose experiences in a community sample of military veterans who use opioids. J Drug Issues. 2017;6:66.","journal-title":"J Drug Issues"},{"issue":"3","key":"604_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0376-8716(96)01309-9","volume":"43","author":"S Darke","year":"1996","unstructured":"Darke S, Ross J, Hall W. Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug Alcohol Depend. 1996;43(3):191\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"604_CR26","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1046\/j.1360-0443.2003.00474.x","volume":"98","author":"S Darke","year":"2003","unstructured":"Darke S, Mattick RP, Degenhardt L. The ratio of non-fatal to fatal heroin overdose. Addiction. 2003;98(8):1169\u201371.","journal-title":"Addiction"},{"key":"604_CR27","unstructured":"Association, A.P., Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). 2013: American Psychiatric Pub."},{"issue":"2","key":"604_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1300\/J514v19n02_05","volume":"19","author":"MW Ross","year":"2007","unstructured":"Ross MW, et al. Stigma consciousness concerns related to drug use and sexuality in a sample of street-based male sex workers. Int J Sex Health. 2007;19(2):57\u201367.","journal-title":"Int J Sex Health"},{"issue":"4","key":"604_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.genhosppsych.2012.02.003","volume":"34","author":"AJ Lang","year":"2012","unstructured":"Lang AJ, et al. Abbreviated PTSD Checklist (PCL) as a guide to clinical response. Gen Hosp Psychiatry. 2012;34(4):332\u20138.","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"604_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1176\/appi.ajp.2012.12071000","volume":"170","author":"WE Narrow","year":"2013","unstructured":"Narrow WE, et al. DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry. 2013;170(1):71\u201382.","journal-title":"Am J Psychiatry"},{"key":"604_CR31","unstructured":"StataCorp, L. Stata survival analysis reference manual. 2017."},{"issue":"7","key":"604_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702\u20136.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"604_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0924-1","volume":"17","author":"R Buels","year":"2016","unstructured":"Buels R, et al. JBrowse: a dynamic web platform for genome visualization and analysis. Genome Biol. 2016;17(1):1\u201312.","journal-title":"Genome Biol"},{"issue":"3","key":"604_CR34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/02791072.2018.1430409","volume":"50","author":"AS Bennett","year":"2018","unstructured":"Bennett AS, et al. From peers to lay bystanders: findings from a decade of naloxone distribution in Pittsburgh, PA. J Psychoactive Drugs. 2018;50(3):240\u20136.","journal-title":"J Psychoactive Drugs"},{"key":"604_CR35","first-page":"66","volume":"6","author":"D Madah-Amiri","year":"2020","unstructured":"Madah-Amiri D, Gjersing L, Clausen T. Naloxone distribution and possession following a large-scale naloxone programme. Addiction. 2020;6:66.","journal-title":"Addiction"},{"issue":"1","key":"604_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/09687637.2014.981509","volume":"22","author":"SM Bird","year":"2015","unstructured":"Bird SM, Parmar MK, Strang J. Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland\u2019s public health policy evaluation, and a new measure to assess impact. Drugs Educ Prev Policy. 2015;22(1):66\u201376.","journal-title":"Drugs Educ Prev Policy"},{"issue":"1","key":"604_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12954-020-00449-1","volume":"18","author":"Z Mamdani","year":"2021","unstructured":"Mamdani Z, et al. \u201cRunning myself ragged\u201d: stressors faced by peer workers in overdose response settings. Harm Reduct J. 2021;18(1):18.","journal-title":"Harm Reduct J"},{"issue":"6","key":"604_CR38","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMc2015435","volume":"383","author":"AH Kral","year":"2020","unstructured":"Kral AH, et al. Evaluation of an unsanctioned safe consumption site in the United States. N Engl J Med. 2020;383(6):589\u201390.","journal-title":"N Engl J Med"},{"issue":"6","key":"604_CR39","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.amepre.2017.06.010","volume":"53","author":"AH Kral","year":"2017","unstructured":"Kral AH, Davidson PJ. Addressing the nation\u2019s opioid epidemic: lessons from an unsanctioned supervised injection site in the US. Am J Prev Med. 2017;53(6):919\u201322.","journal-title":"Am J Prev Med"},{"issue":"4","key":"604_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.17269\/s41997-020-00315-4","volume":"111","author":"N Maghsoudi","year":"2020","unstructured":"Maghsoudi N, Bowles J, Werb D. Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada. Can J Public Health. 2020;111(4):606\u20139.","journal-title":"Can J Public Health"},{"issue":"1","key":"604_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11524-018-0294-y","volume":"96","author":"G Bardwell","year":"2019","unstructured":"Bardwell G, et al. Addressing intersecting housing and overdose crises in Vancouver, Canada: opportunities and challenges from a tenant-led overdose response intervention in single room occupancy hotels. J Urban Health. 2019;96(1):12\u201320.","journal-title":"J Urban Health"},{"key":"604_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.drugpo.2020.102769","volume":"80","author":"A Ivsins","year":"2020","unstructured":"Ivsins A, et al. Tackling the overdose crisis: the role of safe supply. Int J Drug Policy. 2020;80:102\u2013769.","journal-title":"Int J Drug Policy"},{"key":"604_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"145","author":"C Potier","year":"2014","unstructured":"Potier C, et al. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48\u201368.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"604_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0203-9","volume":"14","author":"G Bardwell","year":"2017","unstructured":"Bardwell G, et al. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions? Harm Reduct J. 2017;14(1):1\u20134.","journal-title":"Harm Reduct J"},{"key":"604_CR45","doi-asserted-by":"publisher","first-page":"100474","DOI":"10.1016\/j.eclinm.2020.100474","volume":"25","author":"DG Schwartz","year":"2020","unstructured":"Schwartz DG, et al. Layperson reversal of opioid overdose supported by smartphone alert: a prospective observational cohort study. EClinicalMedicine. 2020;25:100474.","journal-title":"EClinicalMedicine"},{"key":"604_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trsl.2021.03.001","volume":"234","author":"A Bennett","year":"2021","unstructured":"Bennett A, Elliott L. Naloxone\u2019s role in the national opioid crisis-past struggles, current efforts, and future opportunities. Transl Res. 2021;234:43\u201357.","journal-title":"Transl Res"},{"key":"604_CR47","doi-asserted-by":"publisher","first-page":"106376","DOI":"10.1016\/j.healthplace.2020.102376","volume":"64","author":"J Owczarzak","year":"2020","unstructured":"Owczarzak J, et al. \u201cWe know the streets:\u201d race, place, and the politics of harm reduction. Health Place. 2020;64:106376.","journal-title":"Health Place"},{"issue":"2","key":"604_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/15332640.2014.976803","volume":"14","author":"MH Eversman","year":"2015","unstructured":"Eversman MH. \u201cWe Want a Living Solution\u201d: views of harm reduction programs in Black US communities. J Ethnicity Substance Abuse. 2015;14(2):187\u2013207.","journal-title":"J Ethnicity Substance Abuse"},{"key":"604_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2019.107743","volume":"206","author":"AR Ong","year":"2020","unstructured":"Ong AR, Lee S, Bonar EE. Understanding disparities in access to naloxone among people who inject drugs in Southeast Michigan using respondent driven sampling. Drug Alcohol Depend. 2020;206:107\u2013743.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"604_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/1049732318800289","volume":"29","author":"JM Bowles","year":"2019","unstructured":"Bowles JM, Lankenau SE. \u201cI Gotta Go With Modern Technology, So I\u2019m Gonna Give 'em the Narcan\u201d: the diffusion of innovations and an opioid overdose prevention program. Qual Health Res. 2019;29(3):345\u201356.","journal-title":"Qual Health Res"},{"issue":"1_suppl","key":"604_CR51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/1077558700057001S07","volume":"57","author":"TA LaVeist","year":"2000","unstructured":"LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and White cardiac patients. Med Care Res Rev. 2000;57(1_suppl):146\u201361.","journal-title":"Med Care Res Rev"},{"issue":"5","key":"604_CR52","first-page":"327","volume":"17","author":"JO Merrill","year":"2002","unstructured":"Merrill JO, et al. Mutual mistrust in the medical care of drug users: the keys to the \u201cnarc\u201d cabinet. J Gen Intern Med. 2002;17(5):327\u201333.","journal-title":"J Gen Intern Med"},{"key":"604_CR53","unstructured":"Hinton E, Head L, Reed C. An unjust burden: The disparate treatment of Black Americans in the Criminal Justice System. 2018, Vera Institute of Justice: New York."},{"key":"604_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2020.107890","volume":"209","author":"B Suffoletto","year":"2020","unstructured":"Suffoletto B, Zeigler A. Risk and protective factors for repeated overdose after opioid overdose survival. Drug Alcohol Depend. 2020;209:107\u2013890.","journal-title":"Drug Alcohol Depend"},{"key":"604_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2019.107734","volume":"206","author":"CM Cleland","year":"2020","unstructured":"Cleland CM, et al. Between-and within-person associations between opioid overdose risk and depression, suicidal ideation, pain severity, and pain interference. Drug Alcohol Depend. 2020;206:107\u2013734.","journal-title":"Drug Alcohol Depend"},{"key":"604_CR56","doi-asserted-by":"publisher","first-page":"102796","DOI":"10.1016\/j.drugpo.2020.102796","volume":"66","author":"EL Winstanley","year":"2020","unstructured":"Winstanley EL. The bell tolls for thee & thine: compassion fatigue & the overdose epidemic. Int J Drug Policy. 2020;66:102796.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00604-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-022-00604-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00604-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T06:10:28Z","timestamp":1666505428000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-022-00604-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1186\/s12954-022-00604-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-958924\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the New York University School of Medicine Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}